Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Prospective Study to Assess the Safety, Tolerability, Analgesic Effect and Feasibility of Intranasal Sufentanil/Ketamine in Pediatric Patients With Moderate or Severe Pain, in an Acute Care Setting

NCT06364072 is registered in ClinicalTrials.gov with Cessatech A/S as lead sponsor.

NCT NCT06364072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06364072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Prospective Study to Assess the Safety, Tolerability, Analgesic Effect and Feasibility of Intranasal Sufentanil/Ketamine in Pediatric Patients With Moderate or Severe Pain, in an Acute Care Setting
Lead sponsor
Cessatech A/S
Phase
Phase 2/3
Overall status
Completed
Start date
May 27, 2024
Completion date
May 9, 2025
Enrollment
155 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pain